Guardant Health Stock Investor Sentiment

GH Stock  USD 42.89  2.25  5.54%   
Under 58% of Guardant Health's investor base is looking to short. The analysis of overall sentiment of trading Guardant Health stock suggests that many investors are alarmed at this time. Guardant Health's investing sentiment shows overall attitude of investors towards Guardant Health.

Comfort Level 42

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Guardant Health's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Guardant Health.

Guardant Historical Sentiment

Although Guardant Health's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Guardant, such as negative comments on social media and news outlets, may cause fear in the market and push Guardant Health's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Guardant.
  

Guardant Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Guardant Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Guardant Health Historical Investor Sentiment

Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Guardant Health news discussions. The higher the estimate score, the more favorable the investor's outlook on Guardant Health.

Guardant Health Maximum Pain Price Across April 17th 2025 Option Contracts

Guardant Health's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Guardant Health close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Guardant Health's options.
over a month ago at news.google.com         
Disposition of 154 shares by Krognes Steve E. of Guardant Health subject to Rule 16b-3
Google News at Macroaxis
over a month ago at businesswire.com         
Guardant Healths Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal C...
businesswire News
over a month ago at finance.yahoo.com         
Guardant Healths Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal C...
Yahoo News
over a month ago at businesswire.com         
Guardant Healths Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal C...
businesswire News
over a month ago at gurufocus.com         
Guardant Health Inc Partners with Abu Dhabi for Innovative Colorectal Cancer Screening
Gurufocus Stories at Macroaxis
over a month ago at businesswire.com         
Guardant Healths Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal C...
businesswire News
over a month ago at news.google.com         
Guardant Health stock soars to 52-week high of 49.97 - Investing.com
Google News at Macroaxis
over a month ago at gurufocus.com         
Guardant Health Inc Shares Up 4.49 percent on Jan 30
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Guardant Health Inc Announces Upcoming Financial Results Release for Q4 and Full Year 2024
Gurufocus Stories at Macroaxis
over a month ago at businesswire.com         
Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
businesswire News
over a month ago at news.google.com         
The Goldman Sachs Group Issues Positive Forecast for Guardant Health Stock Price - MarketBeat
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Why Guardant Health Is Skyrocketing Now
Yahoo News
over a month ago at thelincolnianonline.com         
Guardant Health Now Covered by Analysts at Barclays
news
over a month ago at news.google.com         
Guardant Health stock target raised to 55 by BTIG - MSN
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Guardant Healths Buy Rating Reaffirmed at Guggenheim
news
Far too much social signal, news, headlines, and media speculation about Guardant Health that are available to investors today. That information is available publicly through Guardant media outlets and privately through word of mouth or via Guardant internal channels. However, regardless of the origin, that massive amount of Guardant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Guardant Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Guardant Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Guardant Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Guardant Health alpha.

Guardant Health Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 94555 shares by Helmy Eltoukhy of Guardant Health subject to Rule 16b-3
12/31/2024
2
Disposition of 2084 shares by Michael Bell of Guardant Health subject to Rule 16b-3
01/03/2025
3
Disposition of 3309 shares by Michael Bell of Guardant Health subject to Rule 16b-3
01/15/2025
4
Disposition of 711 shares by Eagle Craig of Guardant Health at 34.76 subject to Rule 16b-3
01/17/2025
5
Guardant Health Inc Shares Up 4.49 percent on Jan 30
01/30/2025
6
Disposition of 6617 shares by Michael Bell of Guardant Health subject to Rule 16b-3
01/31/2025
7
Disposition of tradable shares by Joyce Meghan V. of Guardant Health subject to Rule 16b-3
02/04/2025
8
These 2 Medical Stocks Could Beat Earnings Why They Should Be on Your Radar
02/13/2025
9
Guardant Health, Inc. Q4 2024 Earnings Call Transcript
02/21/2025
10
Guardant Health Among the Best Performing Mid Cap Stocks to Buy According to Analysts
02/26/2025
11
New Guardant HealthHarris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope fo...
02/27/2025
12
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635
02/28/2025
13
Acquisition by John Saia of 263 shares of Guardant Health subject to Rule 16b-3
03/04/2025
14
Guardant Health Joins Forces With Dak Prescotts Faith Fight Finish Foundation and Feist-Weiller Cancer Centers Partners in Wellness to Boost Colon Cancer Screen...
03/05/2025
15
Guardant Health Trading Down 9.5 percent Should You Sell
03/10/2025
16
Acquisition by Michael Bell of 22332 shares of Guardant Health subject to Rule 16b-3
03/12/2025
17
Guardant Health Inc Stock Price Down 4.16 percent on Mar 13
03/13/2025

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios